Brixadi Alternatives Compared
| Brixadi (buprenorphine) | Suboxone (buprenorphine / naloxone) | Buprenorphine / naloxone |
|
|---|
| Brixadi (buprenorphine) | Suboxone (buprenorphine / naloxone) | Buprenorphine / naloxone |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Opiate Dependence - Maintenance, Opioid Use Disorder. Brixadi may also be used for purposes not listed in this medication guide. |
Prescription only
Suboxone is a combination medicine containing buprenorphine and naloxone that is used to treat adults addicted to opioid medications. It should be used in conjunction with a complete treatment... View more |
Prescription only
Buprenorphine/naloxone is a combination opioid/opioid antagonist tablet which helps to suppress opioid withdrawal symptoms and is used for the maintenance treatment of opioid drug dependence... View more |
Related suggestions Opioid Use Disorder
Popular comparisons
|
|||||||||||||||||||||||
| More about Brixadi (buprenorphine) | More about Suboxone (buprenorphine / naloxone) | More about Buprenorphine / naloxone | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Brixadi has an average rating of 6.0 out of 10 from a total of 2 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 0% reported a negative effect. |
Suboxone has an average rating of 8.5 out of 10 from a total of 729 ratings on Drugs.com. 81% of reviewers reported a positive effect, while 7% reported a negative effect. |
Buprenorphine / naloxone has an average rating of 7.7 out of 10 from a total of 1131 ratings on Drugs.com. 70% of reviewers reported a positive effect, while 16% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Brixadi side effects |
View all Suboxone side effects |
|
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
|
None |
||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Brixadi prices |
View all Suboxone prices |
View all Buprenorphine / naloxone prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other buprenorphine brands include: Belbuca, Buprenex, Butrans, Sublocade | Other buprenorphine / naloxone brands include: Zubsolv | Suboxone, Zubsolv | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
48 hours |
37 hours |
37 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 718 drugs are known to interact with Brixadi:
|
A total of 723 drugs are known to interact with Suboxone:
|
A total of 723 drugs are known to interact with Buprenorphine / naloxone:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
May 23, 2023 |
October 08, 2002 |
October 08, 2002 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Suboxone
Suboxone (buprenorphine and naloxone) is used to treat opiate addiction. Includes Suboxone side ...
Subutex
Subutex (buprenorphine) is used to treat opioid addiction. Includes Subutex side effects ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Belbuca
Belbuca (buprenorphine) is used for chronic pain management. Includes Belbuca side effects ...
Vivitrol
Vivitrol is a long-acting injectable form of naltrexone used to treat alcohol use disorder and ...
Sublocade
Sublocade information from Drugs.com, includes Sublocade side effects, interactions and indications.
Butrans
Butrans (buprenorphine) transdermal patches are used to treat moderate to severe chronic pain ...
Zubsolv
Zubsolv (buprenorphine and naloxone) is used to treat opioid dependence. Includes Zubsolv side ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.